Literature DB >> 10219678

Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography.

S H Lee1, S D Yoo, K H Lee.   

Abstract

This report describes a rapid, simple and sensitive isocratic high-performance liquid chromatography with diode array UV detection for micro-sample analysis of paclitaxel in mouse plasma. The analysis utilized a Capcell-pak octadecyl analytical column and a mobile phase consisting of acetonitrile--0.1% phosphoric acid in deionized water (55:45, v/v). Paclitaxel and n-hexyl p-hydroxybenzoic acid (internal standard) were extracted from plasma by one-step extraction with tert.-butyl methyl ether. Peak purity was determined over a UV wavelength range of 200 to 400 nm. Paclitaxel and the internal standard were eluted at 3.4 min and 5.4 min, respectively, at a mobile phase flow-rate of 1.3 ml/min. No interfering peaks were observed and the total run time was 10 min. The standard curve was linear (r = 0.9999) over the concentration range of 0.010-500 micrograms/ml. The extraction recovery was > 90% for both paclitaxel and n-hexyl p-hydroxybenzoic acid. The intra- and inter-day assay variabilities of paclitaxel ranged from 0.4 to 2.2% and 0.6 to 7.8%, respectively. The LOD and LOQ were 5 and 10 ng/ml, respectively, for paclitaxel using a plasma sample volume of 100 microliters. This highly sensitive and simple assay method was successfully applied to a pharmacokinetic study after i.v. administration of paclitaxel 20 mg/kg to mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219678     DOI: 10.1016/s0378-4347(98)00566-0

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  4 in total

1.  Antitumor effect of the paclitaxel-eluting membrane in a mouse model.

Authors:  Jin-Seok Park; Seok Jeong; Don Haeng Lee; Jin Hee Maeng; In Suh Park; Sangsoo Park
Journal:  Oncol Lett       Date:  2018-07-17       Impact factor: 2.967

2.  A phase I study of flavopiridol and docetaxel.

Authors:  Basil F El-Rayes; Shirish Gadgeel; Ralph Parchment; Patricia Lorusso; Philip A Philip
Journal:  Invest New Drugs       Date:  2006-07       Impact factor: 3.850

3.  Formulation optimization of paclitaxel carried by PEGylated emulsions based on artificial neural network.

Authors:  Tianyuan Fan; Kozo Takayama; Yoshiyuki Hattori; Yoshie Maitani
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

4.  Injectable diblock copolypeptide hydrogel provides platform to deliver effective concentrations of paclitaxel to an intracranial xenograft model of glioblastoma.

Authors:  Matthew C Garrett; Timothy M O'Shea; Alexander L Wollenberg; Alexander M Bernstein; Derek Hung; Brittany Staarman; Horacio Soto; Timothy J Deming; Michael V Sofroniew; Harley I Kornblum
Journal:  PLoS One       Date:  2020-07-24       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.